SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses-Reference-Cited by-同舟云学术

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses

Published:2022-03 Issue:9 Volume:38 Page:110429
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chatterjee Debashree,Tauzin Alexandra,Marchitto Lorie,Gong Shang Yu,Boutin Marianne,Bourassa Catherine,Beaudoin-Bussières Guillaume,Bo Yuxia,Ding Shilei,Laumaea Annemarie,Vézina Dani,Perreault Josée,Gokool Laurie,Morrisseau Chantal,Arlotto Pascale,Fournier Éric,Guilbault Aurélie,Delisle Benjamin,Levade Inès,Goyette Guillaume,Gendron-Lepage Gabrielle,Medjahed Halima,De Serres Gaston,Tremblay Cécile,Martel-Laferrière Valérie,Kaufmann Daniel E.,Bazin Renée,Prévost Jérémie,Moreira Sandrine,Richard Jonathan,Côté Marceline,Finzi Andrés

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study;Allen;Lancet Reg. Health Eur.,2022

2. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2;Amanat;Cell,2021

3. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset;Anand;Cell Rep. Med.,2021

4. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern;Andrews;Preprint at medRxiv,2021

5. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies;Baum;Science,2020

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission;mBio;2024-08-14

2. The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2;PLOS Pathogens;2024-08-02

3. Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine;Journal of Clinical Investigation;2024-07-11

4. Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells;Viruses;2024-03-01

5. Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development;Vaccine;2024-02